Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D0C7GJ | ||||
| Former ID | DIB008442 | ||||
| Drug Name | Long-acting factor VIII | ||||
| Synonyms | PolyXen PSA-Factor VIII; Long-acting factor VIII (PolyXen, blood clotting disorder); Polysialic factor VIII (PolyXen, blood clotting disorder), Lipoxen/Baxter; Long-acting factor VIII (PolyXen, blood clotting disorder), Lipoxen/Baxter | ||||
| Indication | Blood clotting disorder [ICD9: 286; ICD10:D65-D69] | Investigative | [543658] | ||
| Company | Baxter International Inc | ||||
| Target and Pathway | |||||
| Target(s) | Coagulation Factor VIIIa | Target Info | Modulator | [543658] | |
| KEGG Pathway | Complement and coagulation cascades | ||||
| PANTHER Pathway | Blood coagulation | ||||
| PathWhiz Pathway | Coagulation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
